SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 25.18-5.1%Dec 12 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: GregSL who wrote (8325)1/17/1999 11:56:00 AM
From: Bluegreen  Read Replies (3) of 17367
 
Are you saying actions performed by the FDA or a DSMB are incapable of ludicrous behavior? I dare say that most decisions in regard to efficacy of a device or pharmaceutical by the FDA are indeed ludicrous at best. Do you actually think some pompous egghead involved in efficacy studies cares about dying children? I would venture to say most eggheads in that position are interested in their concocted numbers, nothing else. Safety by FDA is in severe trouble also. Recent examples being Redux and Duract. The FDA is only a puppet of a mickey mouse advisory board most of the time anyway. If FDA would concentrate more on safety and less on efficacy we would all be better for it. Only my opinions.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext